학술논문

Population Pharmacokinetics (PopPK) and Exposure-Response (E-R) Analyses for Belantamab Mafodotin Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Enrolled in DREAMM-2 and DREAMM-3
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 3p. Supplement: 1
Subject
Language
English
ISSN
15280020